Re: FDA BRUDAC 2018 Criteria for Interstitial Cystitis/Bladder Pain Syndrome Clinical Trials: Future Direction for Research Reply

被引:4
作者
不详
机构
关键词
D O I
10.1016/j.juro.2018.06.076
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1122 / 1123
页数:2
相关论文
共 2 条
[1]   Pentosan Polysulfate Sodium for Treatment of Interstitial Cystitis/Bladder Pain Syndrome: Insights from a Randomized, Double-Blind, Placebo Controlled Study [J].
Nickel, J. Curtis ;
Herschorn, Sender ;
Whitmore, Kristene E. ;
Forrest, John B. ;
Hu, Peter ;
Friedman, Andrew J. ;
Baseman, Alan S. .
JOURNAL OF UROLOGY, 2015, 193 (03) :857-862
[2]   Pigmentary Maculopathy Associated with Chronic Exposure to Pentosan Polysulfate Sodium [J].
Pearce, William A. ;
Chen, Rui ;
Jain, Nieraj .
OPHTHALMOLOGY, 2018, 125 (11) :1793-1802